Author

Tiffiney R. Hartman

Fox Chase Cancer CenterORCID 0000-0002-9887-5002Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genetics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Research Focus:variant calling· 2 Assay:whole-exome sequencing· 2 Assay:DNA methylation· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Elena V. DemidovaiD· 2 shared Erica A. GolemisiD· 2 shared Michael J. HalliD· 2 shared Sanjeevani AroraiD· 2 shared Andrea D. FormaniD· 1 shared David Y.T. CheniD· 1 shared Ilya G. SerebriiskiiiD· 1 shared Lily HoangiD· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Elena V. DemidovaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Signatures of defective DNA repair and replication in early-onset renal cancer patients referred for germline genetic testing.

Elena V. Demidova, Ilya G. Serebriiskii, Ramilia Vlasenkova, Simon P. Kelow, Mark Andrake, Tiffiney R. Hartman, Tatiana Kent, Richard T. Pomerantz, Roland L. Dunbrack, Erica A. Golemis, Michael J. Hall, David Y.T. Chen, Mary B. Daly, Sanjeevani Arora

The paper identifies DNA repair and replication defects in early-onset renal cancer patients without known germline variants, suggesting these defects contribute to cancer development and may inform treatment strategies.

medRxiv · May 23, 2022 · PreprintGenetic & Genomic Medicine

Prevalence of pathogenic variants in DNA damage response genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer

Tiffiney R. Hartman, Elena V. Demidova, Randy W. Lesh, Lily Hoang, Marcy E. Richardson, Andrea D. Forman, Lisa Jay Kessler, Virginia Speare, Erica A. Golemis, Michael J. Hall, Mary Beryl Daly, Sanjeevani Arora

The paper examines the prevalence of pathogenic variants in DNA damage response genes in early-onset renal cancer patients undergoing genetic testing and finds that DDR gene variants are present in 8.55% of patients.

Scientific Reports · Aug 11, 2020Peer-reviewedGenetics